The Alzheimer's Disease Risk Gene CD2AP Functions in Dendritic Spines by Remodeling F-Actin

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• CD2-associated protein (CD2AP) is a genetic risk factor for late-onset Alzheimer's disease (LOAD).
• The precise mechanisms by which CD2AP influences synaptic dysfunction in LOAD remain unclear.
• CD2AP's role in actin dynamics suggests a potential function in dendritic spines, critical for synaptic plasticity.

Purpose of the Study:

• To investigate the role of CD2AP in dendritic spine morphology and function in neurons.
• To determine if CD2AP dysfunction contributes to synaptic deficits observed in Alzheimer's disease.
• To elucidate the impact of LOAD-associated CD2AP mutations on synaptic structure and actin dynamics.

Main Methods:

• Immunofluorescence to visualize CD2AP and F-actin colocalization in primary mouse cortical neurons.
• Genetic manipulation (depletion and reexpression) of CD2AP in neurons.
• Analysis of spine density, volume, and synapse formation.
• Assessment of neuronal network activity.
• Characterization of F-actin dynamics in neurons with wild-type and mutant CD2AP.

Main Results:

• CD2AP localizes with F-actin in dendritic spines.
• CD2AP depletion reduces spine density, volume, synapse formation, and neuronal network activity.
• Reintroducing CD2AP rescues spine density; blocking amyloid-beta production does not.
• CD2AP overexpression enhances spine formation and synapse development.
• A LOAD CD2AP mutation leads to aberrant actin protrusions and impaired synaptic function by disrupting actin dynamics.

Conclusions:

• CD2AP is crucial for maintaining dendritic spine structure and function in neurons.
• Disruption of CD2AP, particularly via LOAD-associated mutations, contributes to synaptic dysfunction in Alzheimer's disease by altering actin dynamics.
• Targeting CD2AP-mediated actin regulation may offer a therapeutic strategy for LOAD.